Drug Approval | May 10, 2024
Cipla receives 1 observation from USFDA for Kurkumbh facility
The company is committed to address this observation comprehensively within stipulated time
The company is committed to address this observation comprehensively within stipulated time
The product is used to treat amyotrophic lateral sclerosis
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
With this, for all our USFDA facilities, EIRs are in place
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
ORACEA is a trademark of Galderma Holdings, S.A.
The project funding will be done through a mix of internal accruals and debts.
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
The company has reported total income of Rs. 155.79 crores during the period ended March 31, 2024
Subscribe To Our Newsletter & Stay Updated
